Requirements for medical testing of human nucleic acids (Second Edition 2013)
This document was published by the National Pathology Accreditation Advisory Council (NPAAC) whilst under the governance of the Department of Health and Aged Care. From 1 July 2021, the Australian Commission on Safety and Quality in Health Care (the Commission) assumed responsibility for coordinating the National Pathology Accreditation (NPA) Scheme and supporting the development of the pathology accreditation standards.
Requirements for medical testing of human nucleic acids (Second Edition 2013) is currently in use.
The Commission is undergoing a review process for each of the pathology standards. To remain up to date on upcoming consultations and to provide input, please visit the pathology accreditation standards and sign up now for ongoing updates.
For enquiries about the NPA Scheme or the resources, email email@example.com.
The Requirements for Medical Testing of Human Nucleic Acids sets out the standards that apply to medical tests for heritable and non-heritable variants in human nucleic acids. These tests involve the detection, characterisation and quantification of these nucleic acids.
This document must be read in conjunction with the Tier 2 document - Requirements for Medical Pathology Services.
Accessibility - We aim to provide documents in an accessible format. If you're having problems using a document with your accessibility tools, please contact us for help.
Copyright - Unless stated otherwise, materials provided are covered by a Creative Commons Attribution-Non-Commercial-Share Alike (BY-NC-ND) 4.0 International License.